MSI-HIGH
Clinical trials for MSI-HIGH explained in plain language.
Never miss a new study
Get alerted when new MSI-HIGH trials appear
Sign up with your email to follow new studies for MSI-HIGH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to boost cancer immunotherapy
Disease control Recruiting nowThis study is testing a new oral drug called Alintegimod, given alongside standard immunotherapy drugs (ipilimumab and nivolumab), for people with advanced cancers that have spread. The main goals are to find a safe dose and see if the combination helps control the cancer. It is …
Matched conditions: MSI-HIGH
Phase: PHASE1, PHASE2 • Sponsor: 7 Hills Pharma, LLC • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Radioactive 'Seeker' drug targets advanced cancers in first human test
Disease control Recruiting nowThis is a very early, first-in-human study to test the safety and find the right dose of a new radioactive drug called 177Lu-RAD204. It is for adults with advanced solid tumors (like lung, breast, or skin cancer) that have spread and have stopped responding to standard treatments…
Matched conditions: MSI-HIGH
Phase: EARLY_PHASE1 • Sponsor: Radiopharm Theranostics, Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC